Biotech 2003 Life Sciences: Revaluation and Restructuring

G. Steven Burrill

Published by Burrill & Company
ISBN 10: 0974320900 / ISBN 13: 9780974320908
Used / Paperback / Quantity Available: 0
Available From More Booksellers
View all  copies of this book

About the Book

We're sorry; this specific copy is no longer available. AbeBooks has millions of books. We've listed similar copies below.

Description:

Spine creases, wear to binding and pages from reading. May contain limited notes, underlining or highlighting that does affect the text. Possible ex library copy, that’ll have the markings and stickers associated from the library. Accessories such as CD, codes, toys, may not be included. Bookseller Inventory #

About this title:

Book ratings provided by Goodreads:
0 avg rating
(0 ratings)

Synopsis: Recognized as Biotech's investment visionary by Scientific American, G. Steven Burrill has authored this informative and respected report that provides an overview of the latest developments and trends in the biotech and life sciences sectors.

This valuable resource is a "must have" for professionals working in and around these industries. As a member of the financial or capital markets, or in commercial operations, business development, investor relations, or a congressional staff member, take the time to learn the facts and data that prepare you for the future.

Biotech 2003 delivers the latest data on the state of the biotech and the life sciences industries. Arm yourself with this essential 400 page resource. Get the facts behind the news in:

Pharmaceuticals
Diagnostics
Nutraceuticals
Agricultural Biotech
Finance and Capital Markets
Mergers and Acquisitions
Regulatory Agencies
Biodefense

Review qualitative and quantitative analyses of key activities and industry highlights and the prospects for what lies ahead, including:

Technology, product and company developments advancements and setbacks

Legislative bills, regulatory strategies, political agendas, and industry reaction to geopolitical events

Partnering and M&A agreements in the volatile financial market

400 pages of analyses, charts and grafts give the reader a concise and understandable reference to and background on these exciting sectors.

About the Author: G. Steven Burrill, has been named one of Scientific American 50 "visionaries" for advancing the cause of biotechnology by demonstrating its prudent investment value.

The Scientific American 50 Award honors 50 individuals, teams, companies and other organizations for their many accomplishments in 2001-2002, demonstrating, progressive views of what our technological future could be, as well the leadership, knowledge and expertise essential to realizing those visions.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Biotech 2003 Life Sciences: Revaluation and ...
Publisher: Burrill & Company
Binding: Paperback
Book Condition: GOOD

Top Search Results from the AbeBooks Marketplace

1.

G. Steven Burrill
Published by Burrill & Company
ISBN 10: 0974320900 ISBN 13: 9780974320908
Used Paperback Quantity Available: 1
Seller:
ThriftBooks
(Auburn, WA, U.S.A.)
Rating
[?]

Book Description Burrill & Company. Paperback. Condition: Good. A copy that has been read, but remains in clean condition. All pages are intact, and the cover is intact. The spine may show signs of wear. Pages can include limited notes and highlighting, and the copy can include previous owner inscriptions. At ThriftBooks, our motto is: Read More, Spend Less. Seller Inventory # G0974320900I3N00

More information about this seller | Contact this seller

Buy Used
US$ 95.52
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds